Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - COMMON STOCK REPURCHASED
Common Stock Repurchased KPTI - Karyopharm Therapeutics Inc.
111 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR